These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17132766)

  • 1. Insulin-like growth factor I in pregnancy and maternal risk of breast cancer.
    Lukanova A; Toniolo P; Zeleniuch-Jacquotte A; Grankvist K; Wulff M; Arslan AA; Afanasyeva Y; Johansson R; Lenner P; Hallmans G; Wadell G; Lundin E
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2489-93. PubMed ID: 17132766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway.
    Vatten LJ; Holly JM; Gunnell D; Tretli S
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2097-100. PubMed ID: 18708402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
    Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV
    Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.
    Stattin P; Rinaldi S; Biessy C; Stenman UH; Hallmans G; Kaaks R
    J Clin Oncol; 2004 Aug; 22(15):3104-12. PubMed ID: 15284261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
    Rinaldi S; Kaaks R; Zeleniuch-Jacquotte A; Arslan AA; Shore RE; Koenig KL; Dossus L; Riboli E; Stattin P; Lukanova A; Toniolo P
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):48-52. PubMed ID: 15668475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor II and colorectal cancer risk in women.
    Hunt KJ; Toniolo P; Akhmedkhanov A; Lukanova A; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):901-5. PubMed ID: 12223436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk.
    Richardson BE; Peck JD; Wormuth JK
    Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1349-55. PubMed ID: 11142421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal plasma concentrations of insulinlike growth factor-1 and insulinlike growth factor-binding protein-1 in early pregnancy and subsequent risk of preeclampsia.
    Ning Y; Williams MA; Vadachkoria S; Muy-Rivera M; Frederick IO; Luthy DA
    Clin Biochem; 2004 Nov; 37(11):968-73. PubMed ID: 15498523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer.
    Wagner K; Hemminki K; Israelsson E; Grzybowska E; Söderberg M; Pamula J; Pekala W; Zientek H; Mielzynska D; Siwinska E; Försti A
    Breast Cancer Res Treat; 2005 Jul; 92(2):133-40. PubMed ID: 15986122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
    Diorio C; Brisson J; Bérubé S; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):880-8. PubMed ID: 18398029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid hormone levels during pregnancy and incidence of maternal breast cancer.
    Peck JD; Hulka BS; Poole C; Savitz DA; Baird D; Richardson BE
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):361-8. PubMed ID: 11927496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women.
    Johansson H; Gandini S; Bonanni B; Mariette F; Guerrieri-Gonzaga A; Serrano D; Cassano E; Ramazzotto F; Baglietto L; Sandri MT; Decensi A
    Breast Cancer Res Treat; 2008 Mar; 108(1):57-67. PubMed ID: 17468953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cord serum estrogens, androgens, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 in Chinese and U.S. Caucasian neonates.
    Troisi R; Lagiou P; Trichopoulos D; Xu B; Chie L; Stanczyk FZ; Potischman N; Adami HO; Hoover RN; Hsieh CC
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):224-31. PubMed ID: 18199728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of parity on pregnancy hormonal profiles across ethnic groups with a diverse incidence of breast cancer.
    Arslan AA; Zeleniuch-Jacquotte A; Lukanova A; Afanasyeva Y; Katz J; Levitz M; Del Priore G; Toniolo P
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2123-30. PubMed ID: 17119037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts.
    Tworoger SS; Lee IM; Buring JE; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1691-5. PubMed ID: 17684148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women.
    Eliassen AH; Tworoger SS; Mantzoros CS; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):161-4. PubMed ID: 17220346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between critical period of estrogen exposure and circulating levels of insulin-like growth factor-I (IGF-I) in breast cancer: evidence from a case-control study.
    Wu MH; Chou YC; Chou WY; Hsu GC; Chu CH; Yu CP; Yu JC; Sun CA
    Int J Cancer; 2010 Jan; 126(2):508-14. PubMed ID: 19585556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal Down syndrome and the risk of maternal breast cancer.
    Bjørge T; Cnattingius S; Engeland A; Tretli S; Lie RT; Lukanova A
    Epidemiology; 2009 Jul; 20(4):584-9. PubMed ID: 19451822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.